Oncology Business Management | Specialty

PD-L1 Immunotherapy in Bladder Cancer

July 18th 2014

Targeted Immunotherapy in Cancer

July 18th 2014

Future Role of Immunotherapy in Cancer

July 18th 2014

PD-L1 Inhibition With MPDL3280A in Bladder Cancer

July 18th 2014

Adjuvant Ipilimumab in High-Risk Melanoma

July 18th 2014

Checkpoint Inhibitor Combination Strategies

July 18th 2014

Future Role of Checkpoint Inhibitors in Melanoma

July 18th 2014

Checkpoint Inhibitors in Metastatic Melanoma

July 18th 2014

Introduction: Immunotherapy Research Milestones

July 18th 2014

FDA Grants Priority Review to Bevacizumab in Advanced Cervical Cancer

July 15th 2014

The FDA has assigned a priority review designation to bevacizumab (Avastin) plus chemotherapy as a treatment for patients with persistent, recurrent, or metastatic cervical cancer.

Cancer Patients' Use of Electronic Portals Rising

July 15th 2014

As the use of electronic patient portals grows, a new study examines the use of these portals by cancer patients, extending the doctor-patient relationship to new boundaries.

New Bundled Payment Model Nets 34% Reduction in Medical Costs

July 14th 2014

A pilot program that paid oncologists upfront for the patient's full treatment program regardless of the drugs administered resulted in a 34% reduction in medical costs.

The Evolving Use of White Bagging in Oncology

July 9th 2014

Channel dynamics are changing for physician-administered infusible drugs, with implications for practice economics, payer utilization management, site of care, and availability of data for manufacturers.

Four Approaches Oncology Practices Consider When Merging With Hospitals, Academic Medical Centers

July 3rd 2014

With the uncertainty that accompanies health reform, a safe and secure alignment that integrates oncologists with a hospital or academic medical center can be seductive.

Lawmakers Seek to Ease the Burden of Sequestration Cuts

July 2nd 2014

A bill has been proposed in the House of Representatives seeking to ease some of the financial burdens placed on community oncologists by the sequestration. But does it go far enough?

Blinatumomab Receives Breakthrough Therapy Designation for ALL

July 1st 2014

The FDA has granted a breakthrough therapy designation to blinatumomab for the treatment of adult patients with Philadelphia-negative relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL)

Value-Based Payment to Overtake Fee-For-Service by 2020

July 1st 2014

A new survey by McKesson Health Solutions and released at America's Health Insurance Plan's Institute 2014 conference examined the state of value-based reimbursement, and found that of the existing value-based models, payers and hospitals/health systems predict pay-for-performance (P4P) will experience the most growth

340B Drug Program Under Scrutiny

June 25th 2014

Hospitals, community health centers, and clinics that participate in the federal 340B drug pricing program are finding themselves under scrutiny from some members of Congress and the pharmaceutical industry because of recent expansion of the Affordable Care Act.

MGMA Says Plans, Clearinghouses Charging Excessive Fees on Virtual Credit Cards

June 23rd 2014

Some health plans and clearinghouses are charging unreasonable fees for electronic fund transfer (EFT) transactions to providers who accept payment from virtual credit cards

A Third of Practice Managers Surveyed Expect Value-based Contracts to Hurt Bottom Line

June 19th 2014

A third of practice managers and health care executives who participated in a survey about value-based contracts said they expected the agreements to hurt the bottom line of their institution or practice